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Abstract An 85-year-old man with a high risk for open
heart surgery underwent a percutaneous closure of an atrial
septal defect that lacked adequate aortic and superior rims.
To avoid the risk for erosion, a Figulla Flex II ASD
occluder was selected for the procedure. Implantation was
successful, and no complications were observed during the
6 months of follow-up.
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Introduction
The Amplatzer septal occluder (ASO) is the most widely
used device in the transcatheter closure of atrial septal
defects (ASDs). Cardiac erosion is a rare; however, severe
complications occur in 0.2% of patients [1, 2]. The risk for
erosion has been associated with oversized devices and an
inadequate aortic rim [2]. Because the Figulla Flex II ASD
occluder (FFO, Occlutech GmbH, Jena, Germany) disc has
a softer edge compared with other devices, it may reduce
the risk for erosion. We present a case of transcatheter ASD
closure using FFO in a patient with a high morphological
risk for erosion.
Case
An 85-year-old man with a history of recurrent hospital-
ization because of congestive heart failure with pulmonary
hypertension, chronic atrial fibrillation, and chronic kidney
disease was referred to our hospital for ASD closure.
Transthoracic echocardiography (TTE) confirmed a
secundum ASD, right ventricular enlargement, and calcu-
lated shunt ratio (Qp/Qs) of 1.8. Transesophageal
echocardiography (TEE) was performed for a morpholog-
ical assessment (Fig. 1). The maximum diameter of the
defect was 24.1 mm at 30, and the minimum diameter of
the defect was 18.2 mm at 0. The aortic rim was deficient
at 30–60, and the superior rim was deficient at 60–90.
The posterior rim was not floppy and was sufficiently long.
Septal malalignment was observed at 60 and 90. We
assessed the patient as being at a high risk for erosion or
migration of the closure device because of rim deficiency
and septal malalignment. He still complained of shortness
of breath on exertion under medical treatment. Because his
history also placed him at a high risk for open heart sur-
gery, we chose to perform a transcatheter closure using
FFO. Written informed consent was obtained from the
patient and his family prior to the procedure.
Procedure
Percutaneous ASD closure was performed under TEE
guidance. Balloon sizing was measured to be 27 mm. The
FFO size could be 27 or 30 mm because the maximum
diameter of the defect was 24.1 mm. Considering the oval
shape with a minimum diameter of 18.2 mm and aortic and
superior rim deficiency, we chose and deployed a 27-mm
FFO (Fig. 2). A ball-shaped connector design allows a tilt
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of up to 50, facilitating the assessment of deployment.
After release, the device was stable and TEE at 30 and 60
views showed good device conformability with the mis-
aligned septum and minimal left disc tenting of the atrial
free wall into the transverse sinus (Fig. 3). The procedure
was complete.
Follow-up
Patient recovery was uneventful with NYHA 1 during the
6 months of follow-up. TTE revealed adequate sandwich-
ing of the septum and smooth contact with the sinus of
Valsalva (Fig. 4). Pericardial effusion did not increase.
Discussion
Erosion is a rare but severe complication of transcatheter
ASD closure [1, 2]. Aortic rim deficiency and implantation
of an oversized device are risk factors for erosion [2]. Amin
[3] reported that echocardiographic evidence of aortic rim
absence in multiple views, poor posterior rim consistency,
Fig. 1 Transesophageal echocardiography of the atrial septal defect.
Two-dimensional images and defect diameters each at 30 (a–f) and a
three-dimensional right atrial en-face view image (g) are shown. The
maximum defect diameter was 24.1 mm at 30, and the minimum
defect diameter was 18.2 mm at 0. The aortic rim was deficient at
30–60, and the superior rim was deficient at 60–90. The posterior
rim was not floppy and was sufficiently long. Septal malalignment
was observed at 60 and 90
Fig. 2 Transesophageal echocardiographic image after deploying the
Figulla Flex II ASD occluder. The cable remains connected. A ball-
shaped connector design allows a tilt of up to 50, facilitating
placement before release
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septal malalignment, and dynamic changes in ASD indi-
cated an increased risk for erosion. Evidence of device
tenting of the atrial free wall into the transverse sinus, as in
this case, was also a risk factor [3]. The morphological
characteristics of this patient were consequently indicated
as a high risk for erosion using ASO.
FFO is a double-disc occluder that is similar to ASO, but
its left disc utilizes a unique braiding system without a hub,
reducing the amount of material and giving it a lower
profile than ASO. This construction results in a softer
contact with aortic vessel walls if placed adjacent to it [4].
Erosion has not yet been reported in cases wherein FFO
was used [4–6]. Haas et al. [4] reported a registry of
Occlutech device use for 1315 patients. There were no
cases of erosion in the registry. According to device
embolization, 1.1% occurred during implantation and 0.4%
during follow-up. Most defects had no rim, and they clearly
demonstrated an increased risk for device embolization
when balloon sizing was not performed. Therefore, we still
require discussions regarding the interaction differences of
Fig. 3 Transesophageal echocardiographic (TEE) image after
deploying the Figulla Flex II ASD occluder. The device was stable,
and TEE at 30 and 60 views showed good device conformability
with the malaligned septum and minimal left disc tenting of the atrial
free wall into the transverse sinus
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devices and the risk for embolization. However, during
deployment, the left atrial portion has a round, ball-like
shape unlike the flat profile of devices with a double-sided
hub. This prevents a prolapse of the left disc during
implantation, particularly in large ASDs, those without a
rim, or those with a minimal aortic rim [5].
Six months after the procedure, the patient had not
experienced any complications. Because a late occurrence
of erosion or migration has been reported with ASO, we
need to continue close follow-up [7–9]. FFO may be a
solution for patients with a morphologically high risk for
transcatheter ASD occlusion.
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Fig. 4 Transthoracic echocardiographic short axis view after
6 months of follow-up. The device contacts the sinus of Valsalva
smoothly, and the pericardial effusion has not increased
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